Company: SXTPW
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0001213900-25-043779
Chunk: 248

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-05-15
Form: 10-Q
Item: Part II, Item 1
Chunk 248
---
 and President, Director
    (Principal Executive Officer)

    Dated: May 15, 2025
    /s/ Tyrone Miller

    Tyrone Miller

    Chief Financial Officer
    (Principal Financial and Accounting Officer)

40

WA

0001946563
false
Q1
--12-31

    0001946563

    2025-01-01
    2025-03-31

    0001946563
    
      sxtp:CommonStockParValue00001PerShareMember

    2025-01-01
    2025-03-31

    0001946563
    
      sxtp:WarrantsEachWarrantToPurchaseOneShareOfCommonStockMember

    2025-01-01
    2025-03-31

    0001946563

    2025-05-15

    0001946563

    2025-03-31

    0001946563

    2024-12-31

    0001946563
    
      us-gaap:SeriesAPreferredStockMember

    2025-03-31

    0001946563
    
      us-gaap:SeriesAPreferredStockMember

    2024-12-31

    0001946563

    2024-01-01
    2024-03-31

    0001946563
    
      us-gaap:SeriesAPreferredStockMember
      us-gaap:PreferredStockMember

    2024-12-31

    0001946563
    
      us-gaap:CommonStockMember

    2024-12-31

    0001946563
    
      us-gaap:AdditionalPaidInCapitalMember

    2024-12-31

    0001946563
    
      us-gaap:RetainedEarningsUnappropriatedMember

    2024-12-31

    0001946563
    
      us-gaap:AccumulatedOtherComprehensiveIncomeMember

    2024-12-31

    0001946563
    
      us-gaap:ParentMember

    2024-12-31

    0001946563
    
      us-gaap:NoncontrollingInterestMember

    2024-12-